Fidelity Investments’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$63.6K Sell
3,393
-7,219
-68% -$135K ﹤0.01% 3786
2025
Q1
$191K Buy
10,612
+559
+6% +$10.1K ﹤0.01% 3268
2024
Q4
$169K Sell
10,053
-38,052
-79% -$640K ﹤0.01% 3334
2024
Q3
$778K Buy
48,105
+26,184
+119% +$424K ﹤0.01% 2683
2024
Q2
$180K Buy
21,921
+1,259
+6% +$10.3K ﹤0.01% 3066
2024
Q1
$306K Buy
20,662
+185
+0.9% +$2.74K ﹤0.01% 2873
2023
Q4
$297K Buy
20,477
+155
+0.8% +$2.25K ﹤0.01% 2829
2023
Q3
$219K Buy
20,322
+228
+1% +$2.46K ﹤0.01% 2864
2023
Q2
$259K Sell
20,094
-263,538
-93% -$3.4M ﹤0.01% 2869
2023
Q1
$3.74M Sell
283,632
-605,569
-68% -$7.99M ﹤0.01% 2186
2022
Q4
$13.3M Sell
889,201
-659,458
-43% -$9.89M ﹤0.01% 1778
2022
Q3
$18.3M Sell
1,548,659
-864,048
-36% -$10.2M ﹤0.01% 1643
2022
Q2
$27.3M Sell
2,412,707
-5,473
-0.2% -$61.8K ﹤0.01% 1531
2022
Q1
$72.3M Sell
2,418,180
-38,979
-2% -$1.17M 0.01% 1227
2021
Q4
$65.1M Sell
2,457,159
-97,150
-4% -$2.57M ﹤0.01% 1308
2021
Q3
$92.7M Buy
2,554,309
+1,849
+0.1% +$67.1K 0.01% 1136
2021
Q2
$111M Buy
2,552,460
+1,840
+0.1% +$79.9K 0.01% 1080
2021
Q1
$87.2M Buy
2,550,620
+459,310
+22% +$15.7M 0.01% 1130
2020
Q4
$73.2M Sell
2,091,310
-29,430
-1% -$1.03M 0.01% 1168
2020
Q3
$50.9M Sell
2,120,740
-25,530
-1% -$613K 0.01% 1182
2020
Q2
$39.3M Sell
2,146,270
-58,446
-3% -$1.07M ﹤0.01% 1267
2020
Q1
$34.4M Sell
2,204,716
-79,390
-3% -$1.24M ﹤0.01% 1176
2019
Q4
$48.9M Sell
2,284,106
-48,880
-2% -$1.05M 0.01% 1220
2019
Q3
$43.6M Sell
2,332,986
-174,915
-7% -$3.27M 0.01% 1220
2019
Q2
$65.5M Buy
2,507,901
+328
+0% +$8.56K 0.01% 1105
2019
Q1
$64.4M Buy
2,507,573
+7,972
+0.3% +$205K 0.01% 1104
2018
Q4
$57.5M Buy
2,499,601
+2,949
+0.1% +$67.8K 0.01% 1090
2018
Q3
$80.1M Buy
2,496,652
+42,948
+2% +$1.38M 0.01% 1045
2018
Q2
$69.4M Buy
2,453,704
+244,892
+11% +$6.93M 0.01% 1116
2018
Q1
$78.2M Buy
2,208,812
+11,446
+0.5% +$405K 0.01% 1088
2017
Q4
$85.3M Buy
2,197,366
+331,901
+18% +$12.9M 0.01% 1065
2017
Q3
$47.4M Buy
1,865,465
+29,679
+2% +$754K 0.01% 1326
2017
Q2
$50.1M Buy
1,835,786
+2,212
+0.1% +$60.4K 0.01% 1286
2017
Q1
$60.7M Buy
1,833,574
+350,246
+24% +$11.6M 0.01% 1211
2016
Q4
$35.3M Buy
1,483,328
+65,213
+5% +$1.55M ﹤0.01% 1449
2016
Q3
$52M Buy
1,418,115
+35,949
+3% +$1.32M 0.01% 1275
2016
Q2
$30.8M Buy
1,382,166
+23,828
+2% +$531K ﹤0.01% 1482
2016
Q1
$28.3M Buy
1,358,338
+30,450
+2% +$633K ﹤0.01% 1502
2015
Q4
$40.2M Buy
1,327,888
+325
+0% +$9.85K 0.01% 1346
2015
Q3
$32.8M Buy
1,327,563
+5,406
+0.4% +$134K ﹤0.01% 1433
2015
Q2
$42.4M Buy
1,322,157
+1,502
+0.1% +$48.2K 0.01% 1406
2015
Q1
$47.1M Buy
1,320,655
+3,764
+0.3% +$134K 0.01% 1358
2014
Q4
$29.9M Hold
1,316,891
﹤0.01% 1566
2014
Q3
$25.5M Buy
1,316,891
+3,921
+0.3% +$76.1K ﹤0.01% 1640
2014
Q2
$47.7M Buy
1,312,970
+36
+0% +$1.31K 0.01% 1360
2014
Q1
$50.9M Buy
1,312,934
+420,979
+47% +$16.3M 0.01% 1313
2013
Q4
$25.4M Sell
891,955
-164,332
-16% -$4.68M ﹤0.01% 1608
2013
Q3
$37.8M Hold
1,056,287
0.01% 1412
2013
Q2
$35.3M Buy
+1,056,287
New +$35.3M 0.01% 1413